Nasdaq
JBIO
Jade Biosciences, Inc.
- Health Care
- Listed 2021
- 1 day
- +2.5%
- 1 month
- −0.9%
- 1 year
- +184%
$22.24 · Mkt cap $1.10B
At the 6 Aug 2026 close
Nasdaq
Jade Biosciences, Inc.
$22.24 · Mkt cap $1.10B
At the 6 Aug 2026 close
Jade Biosciences, Inc. trades under the ticker JBIO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $1.10B. The last closing price was $22.24, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +184%, and −0.9% over the past month. Returns are price returns and exclude dividends.
This page exists because JBIO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.